Marketing Medical science Physicians 
PM360
SEPTEMBER 28, 2022
For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.
Eversana Intouch
JANUARY 11, 2022
As what Harvard Business Review calls “a tidal wave of resignations” continues — with the highest rates for those ages 30-45 — and, as many pandemic-induced changes continue to alter to the structure of businesses worldwide (including pharma sales and marketing organizations) — many of our basic assumptions, approaches, and priorities need to shift.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Referral MD
FEBRUARY 28, 2025
While medical science advances, too many clinics still rely on cumbersome paperwork. From reducing paperwork headaches to ensuring doctors have accurate, up-to-date patient data, they quietly transform how physicians deliver care. We live in a world of instant communication and on-demand services.
Clarity Engagement Solutions
NOVEMBER 9, 2020
The primary purpose of Medical Science Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. We have highlighted 5 quick tips for MSL to aid them through the process when engaging with KOL’s.
PM360
DECEMBER 20, 2024
When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.
Medgadget
FEBRUARY 17, 2023
This new way of controlling laparoscopic tools the company describes as “endo-robotic surgery” Its leadership sees it as being able to disrupt the existing market, thanks to significant cost reductions, all while offering surgeons capabilities previously only available from very expensive robotic systems.
Clarify Health
MAY 19, 2020
Each drug on the market started off as an idea that successfully overcame many hurdles while thousands (and sometimes millions) of other potential therapies failed along the way. After FDA-approval comes the last critical mile of this journey: bringing the product to market. sales, medical science liaisons, etc.).
Expert insights. Personalized for you.
109 
Let's personalize your content